It is anticipated that the legionnaire disease testing market would expand at a compound annual growth rate (CAGR) of 9%, from US$ 292 million in 2022 to US$ 819.5 million in 2032. A serious kind of pneumonia infection that inflames the lungs is called legionnaire’s disease. Legionella is the bacteria that causes legionnaire’s disease. It …
Tag Archives: Legionnaire Disease Testing Market Sales
Legionnaire Disease Testing Market Assumes the Frontline, Gearing for a Remarkable US$ 819.5 Million Valuation by 2032-FMI Study
Over the course of the projected period, the legionnaire disease testing market is anticipated to increase at a 9% CAGR, from US$ 292 million in 2022 to US$ 819.5 million by 2032. A serious type of pneumonia infection that inflames the lungs is called legionnaire’s disease. The bacteria legionella is the cause of legionnaire’s disease. …